Skip to main content
Clinical Trials/NCT00221052
NCT00221052
Completed
Not Applicable

Relation Between Reduction of the Inflammatory Status and Glucose Metabolism in Healthy Overweight Men

TNO1 site in 1 country20 target enrollmentJune 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Overweight
Sponsor
TNO
Enrollment
20
Locations
1
Status
Completed
Last Updated
19 years ago

Overview

Brief Summary

Overweight increases the risk to develop chronic diseases including type-2 diabetes and cardiovascular disease. The low-grade inflammatory status often seen in overweight subjects is thought to play an important role in disease development.

The purpose of this study is to determine the role of inflammation on glucose metabolism and insulin resistance. In this study the effect of the anti-inflammatory treatment diclofenac on markers of inflammation and on parameters of glucose metabolism will be studied.

Registry
clinicaltrials.gov
Start Date
June 2005
End Date
July 2005
Last Updated
19 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Sponsor
TNO

Eligibility Criteria

Inclusion Criteria

  • Body Mass Index (BMI): 25.1 - 32.0 kg/m2
  • Normal Dutch eating habits

Exclusion Criteria

  • diabetes, cardiovascular disease or hypertension
  • Not suitable to receive diclofenac treatment
  • Extreme physical activity (more than 6 hours/week)
  • Reported slimming or medically prescribed diet

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials